Mandate

Vinge advises RusForest in connection with inter alia rights issue

September 24, 2010

RusForest carries out a rights issue amounting to approximately SEK 440 million, proposes authorisation for an issue in kind to enable acquisition of shares in companies within Nord Timber Group and acquires a majority stake in LDK-3, both companies with operations in the city of Arkhangelsk in North West Russia.

The rights issue and in kind authorisation are subject to resolutions at an extraordinary general meeting to be held on 8 October 2010 and the LDK-3 acquisition is contingent on inter alia Russian anti-monopoly approval, which is expected to be attained before the end of the year. The transactions are prompted by a capital need to facilitate the development of RusForest’s existing operations in Ust Ilimsk, Magistralny and Boguchany as well as enable RusForest’s expansion into North West Russia, which are central steps in RusForest’s development plan to become Russia’s leading independent forestry and sawmilling company.

Vinge has assisted RusForest in questions relating to Swedish law and Vinge’s team has primarily consisted of Göran Nyström, Jesper Schönbeck, Dain Nevonen, Jonas Johansson and Christian Granqvist.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025